Alvopem® (Pemetrexed) Safety Assessment

Clinical trial NCT04843007 · COMPLETED

Trial details

NCT number: NCT04843007
Sponsor: NanoAlvand
Status: COMPLETED
Study type: OBSERVATIONAL

Non Small Cell Lung Cancer Malignant Pleural Mesothelioma

Start date: 2016-03-15
Primary completion: 2020-01-22
Enrollment: 199

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.